Viremia and HIV-1 Drug Resistance Mutations Among Patients Receiving Second-Line Highly Active Antiretroviral Therapy in Chennai, Southern India

Background. A cross-sectional study among individuals receiving second-line antiretroviral treatment was conducted to report on the level of detectable viremia and the types of drug resistance mutations among those with detectable human immunodeficiency virus (HIV) type 1 plasma viral loads (PVLs)....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2012-04, Vol.54 (7), p.995-1000
Hauptverfasser:	Saravanan, Shanmugam, Vidya, Madhavan, Balakrishnan, Pachamuthu, Kantor, Rami, Solomon, Sunil S., Katzenstein, David, Kumarasamy, Nagalingeswaran, Yeptomi, Tokugha, Sivamalar, Sathasivam, Rifkin, Samara, Mayer, Kenneth H., Solomon, Suniti
Format:	Artikel
Sprache:	eng
Schlagworte:	AIDS Anti-HIV Agents - administration & dosage Anti-HIV Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral drugs Antiretroviral Therapy, Highly Active - methods Antiretrovirals Antiviral agents Antivirals Biological and medical sciences Cross-Sectional Studies Darunavir Drug resistance Drug Resistance, Viral Female Genetic mutation HIV HIV 1 HIV Infections - drug therapy HIV Infections - virology HIV-1 - drug effects HIV-1 - genetics HIV-1 - isolation & purification HIV/AIDS Human immunodeficiency virus Human immunodeficiency virus 1 Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology India Infectious diseases Male Medical sciences Memory interference Mutation Mutation, Missense Pharmacology. Drug treatments Polymerase chain reaction Protease inhibitors Retroviridae Sulfonamides - administration & dosage Sulfonamides - pharmacology Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral infections Viral Load Viral Proteins - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!